中美禁毒合作
Search documents
中欧领导人会晤是否将于下周举行?外交部回应
证券时报· 2025-07-17 09:03
Group 1 - The Chinese Ministry of Foreign Affairs spokesperson Lin Jian stated that there is currently no information available regarding the upcoming China-Europe leaders' meeting [2][3] - Lin Jian emphasized that the cooperation among China, Russia, and India aligns with the interests of the three countries and contributes to regional and global peace and stability [4][5] - In response to comments from former US President Trump regarding fentanyl, Lin Jian reiterated that fentanyl is an issue for the United States, not China, and that the responsibility lies with the US itself [6][7]
外交部回应特朗普涉芬太尼言论:美方应以平等、尊重、互惠方式同中方对话
news flash· 2025-07-17 07:23
Core Viewpoint - The Chinese Foreign Ministry emphasizes that fentanyl is an issue for the United States, not China, and criticizes the U.S. for imposing tariffs on Chinese fentanyl, which disrupts dialogue and cooperation in drug control between the two countries [1] Group 1 - The Chinese government has repeatedly stated that the responsibility for fentanyl issues lies with the U.S. itself [1] - The U.S. has ignored China's goodwill and insisted on imposing tariffs on fentanyl, which severely impacts bilateral dialogue and cooperation in drug control [1] - The Chinese Foreign Ministry calls for the U.S. to engage in dialogue with China in a manner that is equal, respectful, and mutually beneficial [1]
伯恩斯称若中方不协调芬太尼问题就要付出代价,外交部驳斥
news flash· 2025-05-14 07:40
Core Viewpoint - The Chinese government asserts that the fentanyl issue is primarily an American problem and criticizes the U.S. for imposing tariffs on fentanyl, which disrupts dialogue and cooperation in drug control between the two countries [1] Group 1 - The Chinese Foreign Ministry emphasizes that fentanyl is a U.S. issue, not a Chinese one, and holds the U.S. responsible for the problem [1] - The imposition of tariffs by the U.S. on fentanyl is viewed as a serious disruption to China-U.S. cooperation in drug control efforts [1] - The Chinese government calls for a dialogue based on equality, respect, and mutual benefit, urging the U.S. to stop its negative rhetoric towards China [1]
外交部:美对华加征芬太尼关税严重冲击中美在禁毒领域对话与合作
第一财经· 2025-05-13 06:45
据央视新闻消息,5月13日,外交部发言人林剑主持例行记者会。有记者就美国对中国加征芬太尼关 税提问。 美方如果真心想同中方合作,就应该停止对华抹黑推责,以平等、尊重、互惠的方式同中方对话。 林剑表示,中方已多次表明芬太尼是美国的问题,不是中国的问题,责任在美国自身。美方无视中方 的善意,对中国无理加征芬太尼关税,这严重冲击中美在禁毒领域的对话与合作,也严重损害中方利 益。 ...
美以芬太尼为借口滥施关税,纯属“内病外治”(钟声)
Ren Min Ri Bao· 2025-04-26 21:58
Core Viewpoint - The recent comments by a U.S. mayor about distributing fentanyl to the homeless highlight the severity of the fentanyl crisis in the U.S., which is often blamed on China, undermining cooperation in drug control between the two nations [1][4]. Group 1: U.S. Fentanyl Crisis - The U.S. has not permanently classified fentanyl, leading to worsening drug abuse and overdose issues, with synthetic opioids causing 75,000 overdose deaths in 2023, accounting for nearly 70% of all drug overdose deaths [2]. - The U.S. consumes 80% of the world's opioids despite having less than 5% of the global population, indicating a significant public health crisis [2]. - A poll by the Sihe Zhiyuan Foundation shows that most Americans believe drug cartels, users, and the government are responsible for the fentanyl crisis, suggesting a need for comprehensive policy reform [2]. Group 2: China's Drug Control Efforts - China maintains a "zero tolerance" policy towards drugs, including fentanyl, and has taken significant steps in drug control, including the comprehensive classification of fentanyl in 2019, making it the first country to do so [3]. - Since China's classification of fentanyl, there have been no reported cases of fentanyl smuggling from China to the U.S., as acknowledged by the U.S. State Department [3]. - China continues to enhance its control over precursor chemicals and collaborates with countries like the U.S. and Mexico to combat the issue of fentanyl and its precursors [3]. Group 3: U.S.-China Cooperation - The establishment of the U.S.-China drug control cooperation working group in 2024 provides a platform for both countries to address global drug issues collaboratively [4]. - Ongoing technical exchanges and regular communication between the two nations' drug enforcement agencies aim to strengthen cooperation in tackling the fentanyl crisis [4]. - China's strong opposition to the U.S. imposing tariffs under the pretext of the fentanyl issue emphasizes the need for mutual respect and factual acknowledgment in bilateral relations [4].
公安部回应美方威胁再加征
券商中国· 2025-02-28 15:39
Core Viewpoint - The Chinese government expresses strong dissatisfaction and firm opposition to the U.S. threat of imposing an additional 10% tariff on Chinese products, citing the fentanyl issue as the reason [1]. Group 1 - The U.S. plans to impose tariffs starting March 4, using the fentanyl crisis as a pretext, which China views as an unjustified action [1]. - China emphasizes its strict drug control policies and international cooperation efforts in combating drug issues, asserting that it has made significant contributions to addressing the fentanyl problem [1]. - The root cause of the fentanyl crisis is identified as domestic issues within the U.S., and China urges the U.S. to focus on reducing domestic drug demand and enhancing law enforcement cooperation [1]. Group 2 - The Chinese government warns that the U.S. approach of shifting blame to other countries will not resolve the underlying issues and could severely impact Sino-U.S. cooperation in drug control [1]. - China calls for the U.S. to correct its erroneous actions and to maintain the positive momentum of bilateral drug control cooperation, which has been hard-won [1].